27.10.2021 13:35

Santander Consumer (SC) Q3 Earnings Surpass Estimates

Folgen
Werbung
Santander Consumer (SC) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $1.80 per share. This compares to earnings of $1.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 38.33%. A quarter ago, it was expected that this consumer finance company would post earnings of $1.92 per share when it actually produced earnings of $3.45, delivering a surprise of 79.69%.Over the last four quarters, the company has surpassed consensus EPS estimates four times.Santander Consumer, which belongs to the Zacks Financial - Consumer Loans industry, posted revenues of $1.89 billion for the quarter ended September 2021, missing the Zacks Consensus Estimate by 5.20%. This compares to year-ago revenues of $2.03 billion. The company has topped consensus revenue estimates just once over the last four quarters.The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.Santander Consumer shares have added about 89.4% since the beginning of the year versus the S&P 500's gain of 21.8%.What's Next for Santander Consumer?While Santander Consumer has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.Ahead of this earnings release, the estimate revisions trend for Santander Consumer was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.50 on $2.02 billion in revenues for the coming quarter and $8.54 on $8.04 billion in revenues for the current fiscal year.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - Consumer Loans is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Santander Consumer USA Holdings Inc. (SC): Free Stock Analysis Report To read this article on Zacks.com click here.
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Santander S.A. (Banco Santander Central Hispano)

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Santander S.A. (Banco Santander Central Hispano)

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
22.11.2021Santander NeutralJP Morgan Chase & Co.
17.11.2021Santander HoldJefferies & Company Inc.
12.11.2021Santander Equal-weightMorgan Stanley
28.10.2021Santander BuyDeutsche Bank AG
28.10.2021Santander BuyKepler Cheuvreux
28.10.2021Santander BuyDeutsche Bank AG
28.10.2021Santander BuyKepler Cheuvreux
28.10.2021Santander OutperformCredit Suisse Group
28.10.2021Santander BuyUBS AG
27.10.2021Santander OutperformRBC Capital Markets
22.11.2021Santander NeutralJP Morgan Chase & Co.
17.11.2021Santander HoldJefferies & Company Inc.
12.11.2021Santander Equal-weightMorgan Stanley
28.10.2021Santander NeutralJP Morgan Chase & Co.
27.10.2021Santander NeutralJP Morgan Chase & Co.
28.07.2021Santander UnderperformJefferies & Company Inc.
15.07.2021Santander UnderperformJefferies & Company Inc.
07.06.2021Santander UnderperformJefferies & Company Inc.
25.02.2021Santander UnderperformJefferies & Company Inc.
03.02.2021Santander UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Santander S.A. (Banco Santander Central Hispano) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Neue Virussorgen: DAX geht tiefrot ins Wochenende -- Ausverkauf in den USA -- Lufthansa fliegt vorerst weiter nach Südafrika -- Tesla verzichtet auf staatliche Förderung -- Software AG, K+S im Fokus

Apple macht iPhone in der Türkei über Nacht mehr als 25 Prozent teurer. Ocugen-Aktie: FDA stoppt Covaxin-Impfstoff. BioNTech prüft Wirksamkeit seines Impfstoffs gegen neue Corona-Variante. Nextcloud legt Beschwerde gegen Microsoft beim Bundeskartellamt ein. Kryptowährungen geben wegen neuer Virusvariante kräftig nach. Deutsche Bank: Entscheidend ob Impfstoffe gegen Variante wirken.

Umfrage

Sind Sie in Kryptowährungen wie Bitcoin, Ether & Co. investiert?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln